Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

A

AKTS

Aktis Oncology Inc

14.22

Nov 02 • 2:26 PM ET -1.72 (-10.77%)

Healthcare Biotechnology USA Small NASD

Peers: TLX CATX DRTS LNTH NVS BCAX BMY RADX LLY AZN

| Held by: VTI IWM XBI VXF VTWO IWO SCHA IWN YALL ITOT

Scroll to Statements

Index	RUT
Market Cap	790.63M
Enterprise Value	284.55M
Income	-
Sales	-
Book/sh	8.76
Cash/sh	9.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	79
IPO	Jan 09, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.62
P/C	1.53
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	16.33
Current Ratio	16.33
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-
EPS next Y	-2.25
EPS next Q	-0.46
EPS this Y	97.72%
EPS next Y	-26.15%
EPS next 5Y	68.48%
EPS past 3/5Y	-47.94% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-55.52%
Sales Q/Q	133.86%
Earnings	Aug 13 AMC
EPS/Sales Surpr.	-0.19% 25.44%

Insider Own	43.37%
Insider Trans	-0.50%
Inst Own	43.74%
Inst Trans	-0.72%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-13.69%
SMA50	-30.24%
SMA200	-32.26%
Trades

Shs Outstand	53.45M
Shs Float	31.50M
Short Float	13.69%
Short Ratio	11.98
Short Interest	4.31M
52W High	34.19 -58.42%
52W Low	14.72 -3.43%
Volatility	5.72% 5.63%
ATR (14)	1.07
RSI (14)	28.74
Beta	-
Rel Volume	2.37
Avg Volume	360.11K
Volume	660,099

Perf Week	-9.63%
Perf Month	-23.25%
Perf Quarter	-37.76%
Perf Half Y	-25.18%
Perf YTD	-47.35%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	36.00
Prev Close	15.93
Price	14.22
Change %	-10.77%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)